These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 28517021)

  • 1. Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry.
    Alatri A; Mazzolai L; Font C; Tafur A; Valle R; Marchena PJ; Ballaz A; Tiraferri E; Font L; Monreal M; Riete Investigators T
    Thromb Haemost; 2017 Jul; 117(8):1630-1636. PubMed ID: 28517021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry.
    Gussoni G; Frasson S; La Regina M; Di Micco P; Monreal M;
    Thromb Res; 2013 Jan; 131(1):24-30. PubMed ID: 23141849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis in patients with cancer-associated venous thromboembolism: Comparison of the RIETE-VTE and modified Ottawa score.
    Pfaundler N; Limacher A; Stalder O; Méan M; Rodondi N; Baumgartner C; Aujesky D
    J Thromb Haemost; 2020 May; 18(5):1154-1161. PubMed ID: 32124545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism.
    Gabara C; Aibar J; Nishimoto Y; Yamashita Y; Prandoni P; Barnes GD; Bikdeli B; Jiménez D; Demelo-Rodríguez P; Peris ML; Nguyen ST; Monreal M;
    J Thromb Haemost; 2024 Aug; 22(8):2234-2246. PubMed ID: 38762019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
    Kraaijpoel N; van Es N; Raskob GE; Büller HR; Carrier M; Zhang G; Lin M; Grosso MA; Di Nisio M
    Thromb Haemost; 2018 Jul; 118(7):1270-1278. PubMed ID: 29864787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of active cancer thromboembolic outcomes. RIETE experience of the Khorana score in cancer-associated thrombosis.
    Tafur AJ; Caprini JA; Cote L; Trujillo-Santos J; Del Toro J; Garcia-Bragado F; Tolosa C; Barillari G; Visona A; Monreal M;
    Thromb Haemost; 2017 Jun; 117(6):1192-1198. PubMed ID: 28276571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of venous thromboembolism in patients with cancer.
    López-Núñez JJ; Trujillo-Santos J; Monreal M
    J Thromb Haemost; 2018 Dec; 16(12):2391-2396. PubMed ID: 30246407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens.
    Trujillo-Santos J; Di Micco P; Dentali F; Douketis J; Díaz-Peromingo JA; Núñez MJ; Cañas I; Mastroiacovo D; Saraiva de Sousa M; Monreal M;
    Thromb Haemost; 2017 Jan; 117(2):382-389. PubMed ID: 27786333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE.
    Weitz JI; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat AE; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
    J Thromb Thrombolysis; 2020 Aug; 50(2):267-277. PubMed ID: 32583306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Di Micco P; Iannuzzo M; Lecumberri R; Guijarro R; Madridano O; Monreal M;
    Thromb Haemost; 2008 Nov; 100(5):905-11. PubMed ID: 18989537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Different Clinical Prognostic Scores in Patients with Pulmonary Embolism and Active Cancer.
    Li X; Hu Y; Lin P; Zhang J; Tang Y; Yi Q; Liang Z; Zhou H; Wang M
    Thromb Haemost; 2021 Jun; 121(6):834-844. PubMed ID: 33450779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
    Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive ability of modified Ottawa score for recurrence in patients with cancer-associated venous thromboembolism: From the COMMAND VTE Registry.
    Nishimoto Y; Yamashita Y; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
    Thromb Res; 2020 Jul; 191():66-75. PubMed ID: 32402995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of the DASH prediction rule: a retrospective cohort study.
    Tosetto A; Testa S; Martinelli I; Poli D; Cosmi B; Lodigiani C; Ageno W; De Stefano V; Falanga A; Nichele I; Paoletti O; Bucciarelli P; Antonucci E; Legnani C; Banfi E; Dentali F; Bartolomei F; Barcella L; Palareti G
    J Thromb Haemost; 2017 Oct; 15(10):1963-1970. PubMed ID: 28762665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical course of isolated distal deep vein thrombosis in patients with active cancer: a multicenter cohort study.
    Dentali F; Pegoraro S; Barco S; di Minno MND; Mastroiacovo D; Pomero F; Lodigiani C; Bagna F; Sartori M; Barillari G; Mumoli N; Napolitano M; Passamonti SM; Benedetti R; Ageno W; Di Nisio M
    J Thromb Haemost; 2017 Sep; 15(9):1757-1763. PubMed ID: 28639418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cohort Study on the Management of Cancer-Associated Venous Thromboembolism Aimed at the Safety of Stopping Anticoagulant Therapy in Patients Cured of Cancer.
    van der Hulle T; den Exter PL; van den Hoven P; van der Hoeven JJ; van der Meer FJ; Eikenboom J; Huisman MV; Klok FA
    Chest; 2016 May; 149(5):1245-51. PubMed ID: 26836911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.
    Cohen AT; Katholing A; Rietbrock S; Bamber L; Martinez C
    Thromb Haemost; 2017 Jan; 117(1):57-65. PubMed ID: 27709226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism in centenarians: Findings from the RIETE registry.
    Lacruz B; Tiberio G; Núñez MJ; López-Jiménez L; Riera-Mestre A; Tiraferri E; Verhamme P; Mazzolai L; González J; Monreal M;
    Eur J Intern Med; 2016 Dec; 36():62-66. PubMed ID: 27495947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.
    Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M;
    Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.